Scandinavian ChemoTech
1,43
SEK
+2,88 %
CMOTEC B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Vær den første som følger denne virksomhed
+2,88%
-18,29%
-34,4%
-20,56%
-44,88%
-33,86%
-91,09%
-80,31%
-96,2%
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Læs mereMarkedsværdi
33,38 mio. SEK
Aktieomsætning
42,31 t SEK
Omsætning
2,82 mio.
EBIT %
-717,73 %
P/E
-
Udbytteafkast, %
-
Finanskalender
4.3
2025
Årsrapport '24
ViserAlle indholdstyper
ChemoTech's Animal Care Enters Strategic Collaboration with Norwegian Veterinary University's Hospital for Equine Medicine
ChemoTech: Animal Care Secures New Sale in Germany, Expanding Support for Veterinary Clinics Treating Domestic Animals
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools